These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 24393926

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Current role of portal vein embolization/hepatic artery chemoembolization.
    Kokudo N, Makuuchi M.
    Surg Clin North Am; 2004 Apr; 84(2):643-57. PubMed ID: 15062666
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Therapeutic approach to hepatocellular carcinoma: a difficult choice.
    Gennari L.
    Ann Ital Chir; 2008 Apr; 79(2):79-80. PubMed ID: 18727268
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
    Park SY, Kim JH, Yoon HJ, Lee IS, Yoon HK, Kim KP.
    Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Unresectable combined hepatocellular-cholangiocellular carcinoma treated with transcatheter arterial chemoembolization and gemcitabine: a case study].
    Sano T, Ishikawa T, Imai M, Owaki T, Sato H, Nozawa Y, Iwanaga A, Seki K, Honma T, Yoshida T, Nishikura K, Ishihara N, Kamimura T.
    Nihon Shokakibyo Gakkai Zasshi; 2018 Apr; 115(12):1069-1077. PubMed ID: 30531113
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A Case of Surgical Resection of a Combined Hepatocellular and Cholangiocarcinoma with Hemobilia from Intraductal Tumor Thrombus].
    Uemura K, Takahashi H, Mino K, Ota T, Shichi S.
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1143-1145. PubMed ID: 29394561
    [Abstract] [Full Text] [Related]

  • 16. Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study.
    Mukund A, V Srinivasan S, Rana S, Vijayaraghavan R, Patidar Y, Arora V, Jindal A, Choudhury A, Shasthry SM, Sarin SK.
    Clin Radiol; 2022 Feb; 77(2):121-129. PubMed ID: 34789395
    [Abstract] [Full Text] [Related]

  • 17. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH, Lee SG, Park EH, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [Abstract] [Full Text] [Related]

  • 18. Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver.
    Topaloğlu S, Sağlam K, Çalık A, Cobanoğlu Ü, Öztürk MH.
    Turk J Gastroenterol; 2014 Apr; 25(2):209-11. PubMed ID: 25003684
    [Abstract] [Full Text] [Related]

  • 19. [Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
    Niinobu T, Shibata T, Fukushima Y, Kitada M, Tukahara Y, Hata S, Ikeda K, Hayashida H, Fuzita J, Takahashi Y, Nakamura T, Suzuki R, Shimano T, Takami M, Ishida T.
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1931-5. PubMed ID: 11086448
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.